Advances in vectored vaccines for poultry
Click here to learn how vaccine design technologies have made huge advances in recent years to overcome challenges that conventional vaccines do not meet.
Search
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. Click here to find out more information and learn more.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Patient Documentary
People with type 2 diabetes are two to four times more likely to develop heart disease compared with people without diabetes
Innovation Through Cooperation
Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
Keep water clean
Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water. Click here to find out more.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Saving Stroke Patients around the world
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Click here to learn about the Angels Initiative.
Harold Heart and Dorothy Diabetes
People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes. Click here to learn more.
Connect with your heart
If you know someone who has type 2 diabetes, they are twice as likely to develop heart failure than those without. Click here to find out more.
We create Value through Innovation for our customers
We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
World Water Day: Good Health Hinges on Good Water
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
Our Expectations
We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. Click here to learn more.
EHS management approach
Our comprehensive EHS framework describes our EHS management system at a corporate level consisting of four elements. Click here to find out more.
Metabolic Diseases
Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide.
Atrial Fibrillation
Click here to learn more information about Boehringer Ingelheim's innovative work in protecting patients with an irregular heart beat from a stroke.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
The Core of our Leitbild
Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
Spotlight on poultry chicken trends
What’s going on in regional poultry markets around the globe? We asked some of our customers! Click here to find out what they had to say and more.
Boehringer Ingelheim & Fighting COVID-19 | Boehringer Ingelheim
Learn how Boehringer Ingelheim may not develop human vaccines but is still part of the medical research collective helping to fight this pandemic.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.